Knockout of CD5 on CAR T Cells Boosts Anti-Tumor Efficacy
by Meagan Raeke The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5, a protein found on the surface of T cells, according to a preclinical study from investigators at the University of Pennsylvania’s Perelman …
Continue reading “Knockout of CD5 on CAR T Cells Boosts Anti-Tumor Efficacy”